Welcome : Guest

Chiasma, Inc. (USA) - Facts, Figures and Analytical Insights

Abstract

This report presents quick facts about Chiasma, Inc., which is principally a Late-Stage Biopharmaceutical Company. Illustrated with 4 tables, the report showcases the company's key markets and market position as against its competitors operating in the industry.

Code: PCP-65993
Price: $200
Company Type: Public
Pages: 6
Date: January 2017
Market Data Tables: 4

 NOTE : Select the checkbox below, and click Add to Cart button to add this report to your shopping cart.
Orphan Drugs......3
Table 1: Specialty Pharma & Orphan Drug Market by Region Worldwide (2015) - Percentage Share Breakdown by Value for Europe, US and Rest of the World......3
Injectable Somatostatin Analogues......4
Table 2: Injectable Somatostatin Analogues Market by Disorder Worldwide (2015) - Percentage Share Breakdown by Value for Acromegaly, Neuroendocrine, and Others......4
Acromegaly & Neuroendocrine Tumors......5
Table 3: Market Shares of Leading Medication for the Treatment of Acromegaly & Neuroendocrine Tumors Worldwide (2015) - Percentage Share Breakdown by Value for Lanreotide, Octreotide Immediate-release (IR), and Octreotide Long-acting Release (LAR)......5
Orphan Drugs......6
Table 4: Market Shares of Leading Orphan Disease Therapeutic Providers by Value Sales Worldwide (2014) - Percentage Breakdown for Pfizer, Inc., Sanofi S.A., and Others......6